Why Private Equity Is Furious Over a Paper in a Dermatology Journal
The sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence.
Continue ReadingThe sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence.
Continue Reading
Join the Discussion